BACKGROUND: Hyperuricemia has been positively associated with hypertension, but whether this association is independent of adiposity and other cardiovascular risk factors remains a matter of debate.
Increasing experimental evidence suggests that hyperuricemia has a pathogenic role in hypertension, mediated by several mechanisms such as inflammation and vascular smooth muscle cell proliferation in the renal microcirculation, endothelial dysfunction, and activation of the renin-angiotensin system (1) (2) (3) . A number of epidemiological studies have shown that increased uric acid concentrations in whites are associated with increased risk for developing hypertension (4 ), although the results are not entirely consistent (5 ) . Recently, a possible association between uric acid and hypertension has been assessed in a Chinese population, but not as thoroughly (6 -9 ) .
Because uric acid concentrations are highly correlated with renal function, obesity, and metabolic abnormalities, the causative role of uric acid in hypertension is still a matter of debate. For example, decreased renal blood flow (10 ) and impaired tubular secretion of uric acid (11 ) have been associated with hyperuricemia in hypertensive patients. In overweight and obese subjects, hyperinsulinemia secondary to insulin resistance may enhance the reabsorption of uric acid and thus contribute to the association of hyperuricemia with hypertension (12 ) . Abdominal obesity is associated with high blood pressure via hyperinsulinemia or insulin resistance (13 ) and may represent a cardiovascular risk factor even within normal body mass index (BMI) 4 values (14 ) . To further explore hyperuricemia and abdominal adiposity in relation to hypertension, we prospectively assessed the association of plasma uric acid concentration with the development of hypertension and progression of blood pressure during 4-year follow-up in a community-based large cohort study of a Chinese population. In addition, we conducted a metaanalysis of previous prospective studies to place our findings in context.
Materials and Methods

STUDY POPULATION
The Qingdao Port Health and Nutrition Examination Survey, established from 1999 to 2000, is a prospective study primarily aimed at evaluating potential risk factors for cardiovascular disease. A total of 9662 people age 25 years and older were recruited from the employees of Qingdao Port (Group) Company, which is one of the largest ports for international trade and ocean shipping in Shandong, China. Men accounted for 77.6% of total participants, which was in agreement with the proportion of male employees at the company. Information about anthropometry, lifestyle, and medical conditions was assessed by interview questionnaires in 2-year cycles. In brief, all participants were individually interviewed with a structured questionnaire in the baseline survey, and the following information was recorded by trained observers: weight, height, waist circumference, systolic and diastolic blood pressure, smoking status, alcohol intake, salt consumption, physical activity, medical history, and medications taken. For women, menstrual cycle status was also recorded. BMI was computed as weight in kilograms divided by the square of height in meters. Waist circumference was measured midway between lower rib margin and iliac crest.
We excluded from this survey participants with unavailable blood sample (n ϭ 255) or with preexisting hypertension (n ϭ 1468), diabetes (n ϭ 110), history of cardiovascular disease or cancer (n ϭ 110), kidney disease (n ϭ 87), or gout (n ϭ 22) at baseline. In follow-up until December 2004, 400 (4.1%) were lost owing to emigration or resignation. The final analytic sample included 7220 participants [mean (SD) age, 37.1 (8.6) years; 73.8% male). The study protocol was approved by the Committee Review Board of the collaborating hospitals.
MEASUREMENT OF BIOCHEMICAL MARKERS
At study entry, subjects were asked to avoid alcohol intake for 3 days before blood collection. A blood sample was collected into an EDTA anticoagulant tube (Vacuette; Greiner Bio-One) for each participant after a 12-h overnight fast, and the plasma was separated by centrifugation and stored at Ϫ70°C. We analyzed plasma uric acid with a Technicon SMA 12-60 analyzer (Technicon) using a colorimetric phosphotungstic acid procedure according to the method of Crowley (15 ) . We measured biochemical variables, including glucose, total cholesterol, triglycerides, creatinine, and HDL cholesterol, with an automatic analyzer (Hitachi 7060). All measurements were taken with blinded quality control specimens in a laboratory at Fu Wai Hospital. We estimated the glomerular filtration rate (GFR) using the abbreviated Modification of Diet in Renal Disease (MDRD) equation as follows: 186.3 ϫ creatinine Ϫ1.154 ϫ age Ϫ0.203 ϫ (0.742 for women), which has been validated in Chinese patients with chronic kidney disease (16 ) . We followed the criteria of the modified Adult Treatment Panel III guideline to define metabolic syndrome and used an Asianspecific waist circumference cutoff point according to American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement (17 ) .
BLOOD PRESSURE STATUS AT BASELINE AND OUTCOME
ASSESSMENT
We measured blood pressure with a random-zero mercury column sphygmomanometer. Participants rested for at least 5 min in a seated position before the initial blood pressure reading was obtained. A physician measured the systolic and diastolic blood pressures 3 times in the left arm of seated participants according to a standardized protocol, and the average of these 3 readings was then calculated to determine the reported blood pressure for that examination. At baseline, we classified eligible subjects into 3 groups according to criteria of the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) (18 ) : optimal (systolic Ͻ120 mmHg and diastolic Ͻ80 mmHg), normal (systolic 120 -129 mmHg or diastolic 80 -84 mmHg), or high normal (systolic 130 -139 mmHg or diastolic 85-89 mmHg) blood pressure. If systolic and diastolic blood pressures belonged to different categories, the higher of the 2 readings was used to determine the blood pressure category.
At follow-up 4 years from baseline, participants underwent routine assessment of their blood pressure using the same standardized protocol, and their blood pressure was reclassified according to JNC VI criteria. We examined 2 outcomes of blood pressure: (1) incidence of hypertension defined as systolic blood pressure of Ն140 mmHg, diastolic blood pressure of Ն90 mmHg, or use of antihypertensive medications; and (2) progression of blood pressure by 1 or more JNC VI categories during follow-up (19 ) .
STATISTICAL ANALYSIS
We tested the distribution of continuous variables for normality with a 1-sample Kolmogorov-Smirnov test. Plasma uric acid was normally distributed in both sexes, with values being higher in men than in women. We classified participants on the basis of sex-specific quartiles of uric acid concentration. We used Cox proportional hazards models to examine the relationship between uric acid concentrations and blood pressure outcomes (incident hypertension and blood pressure progression by Ն1 JNC VI category) during follow-up, adjusting for potential confounding factors. The initial model (model I) was adjusted for age alone. In multivariate models, we further adjusted for baseline BMI, smoking, alcohol intake, physical activity, blood glucose, triglyceride, total cholesterol, HDL cholesterol, creatinine, GFR (log-transformed continuous variable), proteinuria, salt consumption, baseline systolic and diastolic blood pressure, and family history of hypertension (model II), and the above variables plus waist circumference (model III). We used relative risks (RRs) and 95% CIs to estimate the associations of uric acid with hypertension or blood pressure progression during follow-up. To test for a linear trend across uric acid quartiles, we used the median uric acid concentration of each category as a continuous variable in the multivariate model.
We did further joint analyses to assess the effects of abdominal obesity and the number of components of metabolic syndrome (0, 1, 2, or more) present in each individual on the relationship between uric acid and incident hypertension using the method of Simes (20 ) , a modified Bonferroni correction for multiple comparisons. To avoid bias by reverse causality due to subclinical hypertension, we also performed sensitivity analyses by excluding the first 2 years of follow-up. All reported P values are 2-sided, and P Ͻ 0.05 is considered statistically significant. Analyses were performed with SPSS software, version 11.0 (SPSS Inc.).
We performed a metaanalysis of the association between uric acid and hypertension using STATA software (version 7.0; STATA Corp.). Relevant studies were sought by searching the Medline and PubMed databases and by hand-searching the relevant reference lists for all prospective studies published before December 2008 that reported on the relationship between uric acid and the development of hypertension. We estimated the pooled RRs and 95% CIs of the development of hypertension for the highest uric acid category compared with the lowest category using the randomeffects model of DerSimonian and Laird (21 ) incorporating both within-study and between-study variability. Formal tests of between-study heterogeneity were assessed by a 2 statistic.
Results
Baseline characteristics of participants are shown in (Table 2) . After adjustment for age, BMI, and other cardiovascular risk factors, increased plasma uric acid concentrations were associated with higher risk of developing hypertension among men (P ϭ 0.003 for trend) and women (P ϭ 0.006 for trend). After additional adjustment for waist circumference, the RRs for the comparison of participants in the highest and lowest uric acid quartiles were slightly attenuated ( Table 2 ). The association between uric acid and incident hypertension appeared to be stronger in women than in men. By testing for sex difference with sex-specific linear regression analyses, no significant difference in the uric acid-blood pressure relationship was found between men and women (P Ͼ 0.05). In subsidiary analyses, uric acid was analyzed as a continuous variable and for the whole cohort was associated with a 30% increased risk of developing hypertension per 1 SD (71 mol/L) increment (RR 1.30, 95% CI 1.22-1.38; P Ͻ 0.001). At the follow-up examination, the risk of progression to a higher blood pressure group also increased across uric acid quartiles in men (P ϭ 0.02 for trend) and women (P ϭ 0.01 for trend) ( Table 2) . We reanalyzed the relation between uric acid and blood pressure progression according to the seventh report of the JNC (22 ) and obtained similar results (data not shown).
In assessing whether the risk of hypertension was dependent on uric acid and number of components of the metabolic syndrome (0, 1, 2, or more), we found that participants in the highest uric acid quartile who also had 3 or more components of the metabolic syndrome had a greater risk of incident hypertension (RR 4.14, 95% CI 1.68 -7.23; corrected P ϭ 0.02 in men; RR 4.46, 95% CI 1.97-6.89; corrected P ϭ 0.01 in women) than those in the lowest quartile and without components of the metabolic syndrome (Fig. 1, A and B) . Given that abdominal obesity is an important underlying risk factor for the metabolic syndrome, we performed an additional joint analysis to assess waist circumference and uric acid in relation to incident hypertension. Participants with abdominal obesity had a consistently higher risk than those without abdominal obesity (Fig. 2, A and B) , and the P value for interaction was 0.08 for men and 0.07 for women. Compared with those in the lowest uric acid quartile and without abdominal obesity, participants who were in the highest quartile and also had abdominal obesity had a 3.0-fold (95% CI 1.56 -3.97; corrected P ϭ 0.03) 
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Smoking, % Model I was adjusted for age; model II was adjusted for age, BMI, smoking, alcohol intake, physical activity, blood glucose, triglyceride, total cholesterol, HDL cholesterol, creatinine, GFR, proteinuria, salt consumption, baseline systolic and diastolic BP, and family history of hypertension; and model III was additionally adjusted for waist circumference. and 3.4-fold (95% CI 2.10 -3.81; corrected P ϭ 0.02) greater risk of incident hypertension in men and in women, respectively. Because the observed association between hyperuricemia and short-term hypertension incidence could be biased by reverse causality due to subclinical hypertension, we conducted a sensitivity analysis after excluding the first 2 years of follow-up, and the associations were not substantially changed (Supplemental Table 1 , which accompanies the online version of this article at www.clinchem.org/content/vol55/issue11). Because increased uric acid concentrations were positively associated with impaired renal function (online Supplemental Table 2 ), which may contribute to the risk of hypertension, we also conducted a sensitivity analysis in which subjects with impaired renal function were excluded. The results were similar to those of the primary analyses, and the RRs for incident hypertension were 1.36 (95% CI 1.11-1.67) for men (P trend Ͻ 0.001) and 1.80 (95% CI 1.10 -1.17) for women (P trend Ͻ 0.001) for the highest compared with the lowest quartile of uric acid.
METAANALYSIS OF PLASMA URIC ACID AND HYPERTENSION
Our metaanalysis included the present study and 7 previous prospective studies (4, (23) (24) (25) (26) (27) (28) of uric acid, comprising 28 657 participants age 18 -84 years. Of the 8 cohorts, 4 were from the US, 1 from Europe, 2 from Japan, and 1 from China. The average duration of follow-up was 8.3 years (range 4 -30 years). The defi- Adjusted for age, BMI, smoking, alcohol intake, physical activity, blood glucose, triglycerides, total cholesterol, HDL cholesterol, creatinine, GFR, proteinuria, salt consumption, baseline systolic and diastolic blood pressure, and family history of hypertension. nition of hypertension was blood pressure Ն140/90 mmHg (6 cohorts) or Ն160/95 mmHg (2 studies) (4, 27 ) . Reported RRs and 95% CIs of hypertension were adjusted for multiple covariates including alcohol intake (23) (24) (25) (26) (27) (28) , serum cholesterol (23-25, 27, 28 ) , and renal function (26 -28 ) . Because our combined analysis showed a significant heterogeneity in the 8 cohort studies (P Ͻ 0.05) that may be due to the varying definitions of hypertension, we reported the estimated pooled RRs from random-effects model. The pooled RRs for individuals with uric acid in the highest category vs those in the lowest were 1.55 (95% CI 1.32-1.82) (Fig. 3) .
Discussion
Our data showed a positive association between plasma uric acid concentration and the incidence of hypertension and blood pressure progression during 4-year follow-up in a community-based Chinese population. This association was somewhat attenuated after adjustment for waist circumference, suggesting that the association between hyperuricemia and hypertension was partly mediated through the abdominal obesity.
The strengths of the study included the large number of participants, prospective design, and a systematic review. Our findings were corroborated by a metaanalysis of 7 previous prospective studies. Collectively, hypertension risk was 55% greater in those in the highest category of uric acid compared with those in the lowest. We also controlled for potential confounding factors by adjusting for renal function, dyslipidemia, and waist circumference. Another major consideration is that observed association between hyperuricemia and short-term incidence of hypertension could be biased by reverse causality due to subclinical hypertension. However, our secondary analysis excluding the first 2-year follow-up yielded similar results.
Recent evidence suggest that an association between uric acid and blood pressure progression is plausible, including the direct role of uric acid in vascular smooth muscle cell proliferation (29 ) , endothelial dysfunction and decreased nitric oxide production (30, 31 ) , local activation of the renin-angiotensin system (32 ) , and its relation to insulin resistance (33 ) . Uric acid usually has an antioxidant effect; however, uric acid becomes a strong oxidant in the environment of obesity (34 ) . Inflammation and oxidative stress in- duced by obesity may predispose individuals to a higher risk for hypertension.
In the current study, the incidence of hypertension was also significantly associated with the component number of the metabolic syndrome. Moreover, joint exposure to high uric acid concentrations and abdominal obesity was associated with higher risk of incident hypertension than their individual effects. These findings were supported by the high correlation between hyperuricemia and obesity. In overweight and obese subjects, uric acid and hyperinsulinemia/insulin resistance interact at the level of the kidney. Hyperinsulinemia causes a marked decrease in the urinary excretion of uric acid, accompanied by decreased sodium and potassium excretion, which may be one of the reasons for the high frequency of hypertension in the metabolic syndrome (12 ) . In particular, abdominal obesity is associated with high blood pressure via hyperinsulinemia (13 ) and may represent a cardiovascular risk factor even within normal BMI values (14 ) . This observational study did not clarify the time sequence of hyperuricemia and abdominal obesity. A prospective study in Korea, however, suggested that a higher uric acid concentration predicted development of the metabolic syndrome (33 ) , and hyperuricemia has been considered to be a component of the metabolic syndrome (34, 35 ) .
Our study has some potential limitations. Although the accuracy of the abbreviated MDRD equation for estimating renal function has been evaluated in Chinese patients with chronic kidney disease in a previous study (16 ) , data in the general population are still sparse. Thus, residual confounding by estimated GFR could not be completely excluded in the association of uric acid and blood pressure tracking in the present study. One limitation of this study is the lack of information on diet and drinks (such as beer), which can influence uric acid concentrations and thus may also contribute to hyperuricemia (4 ) . However, we adjusted for alcohol intake in our models to assess the relation between increased uric acid concentrations and incident hypertension. Recently, it has been shown that uric acid is positively associated with the gene encoding angiotensin-converting enzyme (ACE, I/D polymorphism) in a Chinese population (36, 37 ) . Thus, we could not exclude the possibility that genetic variants may contribute to the association between uric acid and the risk of developing hypertension.
In conclusion, this prospective study suggests that increased plasma uric acid concentrations were associated with increased risk of incident hypertension and progression of blood pressure in Chinese population. The association between hyperuricemia and hypertension was partly mediated by abdominal obesity.
